Effects of experimental chemoendocrine therapy with a combination of a pure antiestrogen and 5-fluorouracil on human breast cancer cells implanted in nude mice

Yutaka Ogasawara, Hiroyoshi Doihara, Kouji Shiroma, Yoshiaki Kanaya, Nobuyoshi Shimizu

Research output: Contribution to journalArticle

8 Citations (Scopus)


The antitumor effects of an experimental chemoendocrine therapy combining a new pure antiestrogen ICI 182780 and 5-fluorouracil (5-FU) were studied on MCF-7 human breast cancer cells implanted in nude mice. ICI 182780 had a dose-dependent antitumor activity, which was potentiated by the concomitant use of 5-FU. When compared with the control group, the estrogen receptor (ER) level in the ICI 182780 group was lower and that in the combination group was markedly lower. Cell cycle analysis by flow cytometry (FCM) resulted in a lower percentage of S-phase cells (%S) in the treated mice. No significant difference was observed in the 5-FU concentrations in tumor cells, while the 5-FU content in RNA was significantly higher in the combination group. The changes in free thymidylate synthetase (TS) concentration indicated TS synthesis after the administration of 5-FU to be more greatly suppressed in the combination group than in the 5-FU group. These results suggest that ICI 182780 and 5-FU exert their combination effect mainly on ER-positive cells, and that the suppression of TS synthesis in tumor cells and the potentiation of the 5-FU-induced metabolic dysfunction of RNA are thus involved in the mode of action of this combination therapy.

Original languageEnglish
Pages (from-to)149-156
Number of pages8
JournalSurgery today
Issue number2
Publication statusPublished - Jan 1 1999



  • 5-fluorouracil
  • Breast cancer
  • Chemoendocrine therapy
  • Nude mouse
  • Pure antiestrogen

ASJC Scopus subject areas

  • Surgery

Cite this